Table 2.
Summary of the GeneLEAD results on clinical samples.
| GeneLEAD results | Clinical samples | ||||||
|---|---|---|---|---|---|---|---|
| Culture positive | Culture negative | ||||||
| AFB per field | AFB per field | ||||||
| ≥100 | 10–99 | 1–9 | <1 >10/slide | 0 | <1 >10/slide | 0 | |
| Positive (n = 63) | 10 | 17 | 11 | 5 a | 16 | 1 c | 3 d |
| Negative (n = 49) | 0 | 1 b | 1 b | 1 b | 0 | 0 | 46 |
| Total (n = 112) | 10 | 18 | 12 | 6 | 16 | 1 | 49 |
a
Including one sample that grew M. chelonae/immunogenum.
b
Identified as M. xenopi.
c
Sample from a patient under treatment for active TB.
d
Three AFB-negative samples from patients under treatment for active TB.